A Common Tag Nucleotide Variant in MMP7 Promoter Increases Risk for Hypertension via Enhanced Interactions With CREB (Cyclic AMP Response Element-Binding Protein) Transcription Factor

• Published in: Hypertension (Dallas, Tex. 1979) Tex. 1979), 2019-12, Vol.74 (6), p.1448-1459
• Main Authors: Subramanian, Lakshmi, Maghajothi, Sakthisree, Singh, Mrityunjay, Kesh, Kousik, Kalyani, Ananthamohan, Sharma, Saurabh, Khullar, Madhu, Victor, Suma M., Swarnakar, Snehasikta, Asthana, Shailendra, Mullasari, Ajit S., Mahapatra, Nitish R.
• Format: Article
• Language: English
• Subjects: Analysis of Variance; Case-Control Studies; Cyclic AMP Response Element-Binding Protein - genetics; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Hypertension - epidemiology; Hypertension - genetics; India - epidemiology; Male; Matrix Metalloproteinase 7 - genetics; Polymorphism, Single Nucleotide - genetics; Predictive Value of Tests; Prevalence; Promoter Regions, Genetic - genetics; Retrospective Studies; Risk Assessment; Urban Population
• ISSN: 0194-911X; 1524-4563
• DOI: 10.1161/HYPERTENSIONAHA.119.12960

MMP (matrix metalloproteinase)-7—a potent extracellular matrix degrading enzyme—is emerging as a new regulator of cardiovascular diseases. However, potential contributions of MMP7 genetic variations to hypertension remain unknown. In this study, we probed for the association of a tag single-nucleotide polymorphism in the MMP7 promoter (−181A/G; rs11568818) with hypertension in an urban South Indian population (n=1501). The heterozygous AG genotype significantly increased risk for hypertension as compared with the wild-type AA genotype (odds ratio, 1.60 [95% CI, 1.25–2.06]; P=2.4×10−4); AG genotype carriers also displayed significantly higher diastolic blood pressure and mean arterial pressure than wild-type AA individuals. The study was replicated in a North Indian population (n=949) (odds ratio, 1.52 [95% CI, 1.11–2.09]; P=0.01). Transient transfection experiments using MMP7 promoter-luciferase reporter constructs revealed that the variant −181G allele conferred greater promoter activity than the −181A allele. Computational prediction and structure-based conformational and molecular dynamics simulation studies suggested higher binding affinity for the CREB (cyclic AMP response element-binding protein) to the −181G promoter. In corroboration, overexpression/downregulation of CREB and chromatin immunoprecipitation experiments provided convincing evidence for stronger binding of CREB with the −181G promoter. The −181G promoter also displayed enhanced responses to hypoxia and epinephrine treatment. The higher promoter activity of −181G allele translated to increased MMP7 protein level, and MMP7−181AG heterozygous individuals displayed elevated plasma MMP7 levels, which positively correlated with blood pressure. In conclusion, the MMP7 A-181G promoter polymorphism increased MMP7 expression under pathophysiological conditions (hypoxic stress and catecholamine excess) via increased interactions with CREB and enhanced the risk for hypertension in its carriers.